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Abstract Isochrysis galbana, a marine prymnesiophyte micro-
alga, is rich in long chain polyunsaturated fatty acids such as
docosahexaenoic acid (C22:6n-3, v4;7;10;13;16;19). We used a
polymerase chain reaction-based strategy to isolate a cDNA,
designated IgASE1, encoding a polyunsaturated fatty acid-
elongating activity from I. galbana. The coding region of 263
amino acids predicts a protein of 30 kDa that shares only limited
homology to animal and fungal proteins with elongating activity.
Functional analysis of IgASE1, by expression in Saccharomyces
cerevisiae, was used to determine its activity and substrate
specificity. Transformed yeast cells specifically elongated the
C18-v9 polyunsaturated fatty acids, linoleic acid (C18:2n-6,
v9;12) and K-linolenic acid (C18:3n-3, v9;12;15), to eicosadienoic
acid (C20:2n-6, v11;14) and eicosatrienoic acid (C20:3n-3,
v11;14;17), respectively. To our knowledge this is the first time
such an elongating activity has been functionally characterised.
The results also suggest that a major route for eicosapentaenoic
acid (C20:5n-3, v5;8;11;14;17) and docosahexaenoic acid syntheses
in I. galbana may involve a v8 desaturation pathway. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
In humans, g6 (n-6) and g3 (n-3) long chain polyunsatu-
rated fatty acids (PUFAs) are obtained directly from the diet
or synthesised from dietary linoleic acid (LA, C18:2n-6, v9;12)
and K-linolenic acid (ALA, 18:3n-3, v9;12;15), respectively.
Long chain PUFAs such as arachidonic acid (AA, C20:
4n-6, v5;8;11;14), eicosapentaenoic acid (EPA, C20:5n-3,
v5;8;11;14;17) and docosahexaenoic acid (DHA, C22:6n-3,
v4;7;10;13;16;19) are considered important as structural compo-
nents of membrane glycerolipids and as precursors of the
eicosanoids, including the biologically active prostaglandins
and leukotrienes [1]. AA and DHA are of special importance
in the brain and blood vessels, and are considered essential for
pre- and post-natal brain and retinal development [2]. Certain
human medical conditions may be related to an imbalance in
the intake and/or metabolism of the g3 and g6 PUFAs re-
sulting in some dysfunction in eicosanoid metabolism [3]. The
diet of most modern societies is nowadays relatively low in g3
PUFAs with a concomitant increased level of g6 PUFA in-
take, largely resulting from a preference for plant-seed oils
and food products from intensively bred animals. The g3
PUFAs, EPA and DHA, for example, are usually obtained
from ¢sh oils and other marine organisms, and their con-
sumption has decreased signi¢cantly in recent years [3]. There
is therefore interest in obtaining them from other sources and
particularly in genetically engineering the potential to syn-
thesise such products in agronomically important oil seed spe-
cies.
The conversion of dietary LA and ALA to long chain PU-
FAs requires further desaturation and elongation reactions,
possibly as depicted in Fig. 1. The common route is that
both LA and ALA are ¢rst desaturated by a v6 desaturase,
then a chain-elongating system adds two carbons to the hy-
drocarbon chains, followed by a further desaturation to yield
AA and EPA, respectively [4,5]. These two pathways are re-
ferred to here as the g6 (v6) and g3 (v6) pathways, since the
¢rst step involves v6 desaturation. However, recent evidence
suggests that alternative modes of synthesis may exist in some
organisms. For example, the production of long chain PUFAs
could involve a v8 desaturation step, and a v8 desaturase gene
has been isolated from Euglena [6]. Such biosynthetic path-
ways would require the initial elongation of 18:2n-6 and
18:3n-3, rather than desaturation, producing eicosadienoic
acid (EDA, C20:2n-6, v11;14) and eicosatrienoic acid (ETrA,
C20:3n-3, v11;14;17), respectively. v8 desaturase activity would
then yield dihomo-Q-linolenic acid (DGLA, C20:3n-6, v8;11;14)
and eicosatetraenoic acid (ETA, C20:4n-3, v8;11;14;17) for sub-
sequent conversion to AA and DHA (Fig. 1). To distinguish
these modes of synthesis from the previous ones, they are
referred to here as the g6 (v8) and g3 (v8) pathways.
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Desaturases involved in PUFA production have been the
subject of intensive study in recent years, and many desaturase
genes have been isolated [7]. In contrast, only a few genes
encoding PUFA-elongating activities have been characterised,
and all appear to be related to the ELO gene family of Sac-
charomyces cerevisiae [8]. To identify GLELO, which encodes
an activity involved in elongating the two v6-desaturated C18
PUFAs Q-linolenic acid (GLA, C18:3n-6, v6;9;12) and steari-
donic acid (STA, C18:4n-3, v6;9;12;15), Parker-Barnes et al. [9]
constructed a Mortierella alpina cDNA library in a yeast ex-
pression vector and screened yeast clones for the ability to
elongate GLA to DGLA (see Fig. 1). The other genes encod-
ing PUFA-speci¢c elongating activities, HELO1 from Homo
sapiens [5] and F56H11.4 from Caenorhabditis elegans [10],
were identi¢ed via their sequence homology to yeast ELO2,
which is involved in the elongation of saturated fatty acids [8].
Zhang et al. [11] have recently reported a human retinal pho-
toreceptor-speci¢c gene, ELOVL4, which may be involved in
one of the three elongation steps required for DHA biosyn-
thesis [12,13]. A 5-bp deletion in the coding region of this gene
may be responsible for two related forms of autosomal dom-
inant macular dystrophy [11].
The fatty acid elongation system of both plants and animals
is generally considered to comprise a rate-limiting condensing
enzyme together with two reductases and one dehydrase; the
latter three components are thought to be present constitu-
tively or induced by the condensing enzyme [14,15]. It is there-
fore considered that it is the condensing enzyme that deter-
mines the substrate speci¢city in terms of chain length and the
degree of desaturation of fatty acid substrates. In support of
this concept, constitutive expression of the normally seed-spe-
ci¢c condensing enzyme encoded by the fatty acid elongation
1 gene (FAE1) in transgenic Arabidopsis was su⁄cient to bring
about the synthesis of C20 and C22 fatty acids in non-seed
tissues [15].
In order for pathways involving v8 desaturation to operate
(Fig. 1) it is possible that speci¢c elongases for v9-desaturated
PUFAs may exist. Here we describe the isolation and charac-
terisation of a cDNA encoding a protein with such an elon-
gating activity from the DHA-rich microalga, Isochrysis gal-
bana.
2. Materials and methods
2.1. Cultivation of I. galbana
I. galbana CCAP 927/1 was obtained from the Culture Collection of
Algae and Protozoa, Centre for Coastal and Marine Sciences, Dun-
sta¡nage Marine Laboratory, Oban, Argyll, UK. The algal cultures
were grown in f/2 medium [16] in an orbital incubator at 100 rpm and
14‡C with continuous white light of intensity of about 30 Wmol/m2/s.
2.2. Isolation of total and poly(A)+ RNA from I. galbana
Algal cultures were harvested by centrifugation at 3000Ug for
5 min. The cell pellet was ground to a ¢ne powder under liquid nitro-
gen with a pestle and mortar before being suspended in 5 ml of
TriPure1 Isolation Reagent (Roche). Total RNA was then isolated
following the manufacturer’s protocol. Poly(A) RNA was prepared
with an mRNA isolation kit (Amersham Pharmacia Biotech).
2.3. cDNA library construction
Double-stranded, end-adapted cDNA synthesised using a cDNA
synthesis kit (Stratagene) was passed through a Sephacryl S-400
Spun Column (Amersham Pharmacia Biotech) to remove adapters
and small cDNA molecules. cDNA eluted from the column was phe-
nol-extracted, ethanol-precipitated and ligated to the arms of the Uni-
Zap vector (Stratagene) before packaging into V phage using the
Ready-To-Go Lambda Packaging Kit (Amersham Pharmacia Bio-
tech). A primary library of 1U106 pfu was obtained with the majority
of the inserts examined ranging from 0.4 to 2 kb. The library was
subsequently ampli¢ed.
2.4. PCR ampli¢cation and cloning of overlapping segments of
a putative elongase cDNA
A degenerate primer EloR2 was designed based on the conserved
motif MYXYYF/GL in ELO-like open reading frames (ORFs) (Fig.
2) and was used in touchdown PCR in conjunction with a universal
T3 promoter primer (5P-AATTAACCCTCACTAAAGGG-3P) using
an aliquot of the ampli¢ed I. galbana cDNA library as template.
The PCR conditions were: one initial denaturation step of 94‡C for
3 min; four cycles of 94‡C for 15 s, 52‡C for 30 s and 72‡C for 45 s;
10 cycles of 94‡C for 15 s, 52‡C (decreasing by 1‡C in each successive
cycle) for 30 s, 72‡C for 45 s; 25 cycles of 94‡C for 15 s, 42‡C for 30 s
Fig. 1. Possible modes of g3 and g6 long chain PUFA biosynthesis. The g6 (v6) and g3 (v6) pathways for the synthesis of very long chain
PUFAs start with v6 desaturation of the C18 fatty acids, LA and ALA, followed by 2-carbon elongation and then further desaturation and
elongation steps. The g6 (v8) and g3 (v8) pathways start with chain elongation followed by v8 desaturation, then further desaturation and
elongation steps to produce the ¢nal products AA and DHA, respectively.
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and 72‡C for 45 s (increasing by 3 s in each successive cycle); one ¢nal
extension step of 72‡C for 6 min. The resultant putative elongase 5P
end fragment of about 650 bp was gel-puri¢ed and cloned into plas-
mid pCR2.1-TOPO using the TOPO TA cloning system (Invitrogen).
The insert of one recombinant plasmid was sequenced and the gene-
speci¢c (sense) primer IgEloF1 (5P-ACTCGAAGCTCTTCACATGG-
3P) synthesised for use in a further library PCR reaction with a uni-
versal M13 forward primer (5P-GTAAAACGACGGCCAGT-3P)
under the following conditions: one initial denaturation step of
94‡C for 3 min; 10 cycles of 94‡C for 15 s, 55‡C for 30 s and 72‡C
for 90 s; 20 cycles of 94‡C for 15 s, 55‡C for 30 s, and 72‡C for 93 s
(increasing by 3 s in each successive cycle); one ¢nal extension step of
72‡C for 6 min. The resultant putative elongase 3P end fragment of
about 850 bp was gel-puri¢ed, cloned and sequenced.
2.5. Functional analysis of the IgASE1 ORF by expression in yeast
The entire IgASE1 coding region was ampli¢ed from the I. galbana
cDNA library with primers IgEloBeg 5P-GGTACCATGGCCCTCG-
CAAACGA-3P (ORF start codon indicated by bold type; underlined
sequence is an added KpnI site) and IgEloEnd 5P-TAAGGACATC-
CACAATCCAT-3P (primes 60 bp downstream of the ORF stop co-
don). The Expand High Fidelity PCR System (Roche) was employed
to minimise potential PCR errors. The resultant 860-bp product was
cloned in pCR2.1-TOPO (as above) and recombinant plasmids
checked for insert orientation. The insert from a selected clone was
excised with KpnI and SacI and ligated into the corresponding restric-
tion sites of yeast expression vector pYES2 (Invitrogen), downstream
of the GAL1 promoter. The ligation mixture was used to transform
Escherichia coli TOP10 cells (Invitrogen), from which the recombinant
plasmid designated pY2ASE1 was isolated and used to transform S.
cerevisiae strain W303-1A to uracil independence by the lithium ace-
tate method [17]. Expression of IgASE1 was induced by the addition
of galactose to 2% (w/v) to cultures grown on ra⁄nose as described
[10,18]. After induction, the cultures were grown for 48 h at 22‡C in
selective medium with individual fatty acid substrates added to 0.1 M
and Tergitol Type NP-40 (Sigma) added to 1%.
2.6. Fatty acid analysis
Microalgal or yeast cells were pelleted, washed and dried under a
stream of N2. Total fatty acids were extracted and transmethylated
with methanolic HCl. Fatty acid methyl esters were analysed by gas
chromatography (GC) using heptadecanoic acid as an internal stan-
dard on a 30 mU0.25 mm DB-23 capillary column (J and W Scien-
ti¢c).
2.7. DNA and protein sequence analysis
DNA sequences were determined using an ABI 377 automatic se-
quencer (Perkin Elmer). The sequence was translated into amino acid
sequence using DNAMAN Sequence Analysis Software (Lynnon Bio-
soft), and the output transferred to BlastP for homology searches.
3. Results
3.1. Isolation of a cDNA encoding a PUFA-elongating activity
We selected I. galbana as the source organism from which
to isolate genes involved in EPA and DHA production. Fatty
acid analysis of I. galbana cultivated as described above
showed that it contained some 12% DHA (Table 1). Other
major unsaturated fatty acids present were 18:1n-9, v9, 18:3n-
3, v9;12;15, 18:4n-3, v6;9;12;15 and 20:1n-9, v11. It is noteworthy
that small amounts of 18:2n-6, v9;12 and 20:5n-3, v5;8;11;14;17
were also present.
The strategy used to isolate a gene encoding a PUFA-elon-
gating activity was to construct and amplify a directional
cDNA library and screen it by PCR using degenerate primers
based on single conserved motifs and universal primers lo-
cated in £anking vector sequences. The degenerate primer
EloR2 was designed as the reverse complement of the con-
served motif MYXYYF/GL in ELO-like ORFs [5,9,11,
10,19]. An alignment of the sequences on which the primer
design was based is shown in Fig. 2. The primer combination
EloR2/T3 ampli¢ed a 650-bp product from the library; se-
quence analysis of the cloned PCR product revealed a contin-
uous ORF extending from a putative start codon to the
MYXYYF/GL motif. The 5P region of the cDNA consisted
of a single G upstream of the putative start codon. A further
16 bases of putative 5P untranslated region were determined
by 5P rapid ampli¢cation of cDNA ends (data not shown).
However, the data do not exclude the possibility that the ¢rst
ATG codon of the cDNA encodes an internal methionine
residue.
To amplify the 3P region of the cDNA from the library the
gene-speci¢c sense primer IgEloF1 was used with the universal
M13 forward primer. A PCR product of about 850 bp was
cloned and sequenced; the 5P and 3P PCR product sequences
overlapped by 235 bp, con¢rming that they were ultimately
derived from a single gene (IgASE1). The presence of 17 bases
of poly(A) tail indicated that the cDNA was complete at the
3P end, and that the 3P untranslated region of the IgASE1
mRNA was 253 bases.
Assuming the coding region of the cDNA to be full length,
IgASE1 encodes a protein of 263 amino acids with a molec-
ular mass of 30 kDa. The deduced amino acid sequence of
IgASE1 aligned with other proteins with elongating activity is
shown in Fig. 2. Hydropathy analysis predicts multiple mem-
brane-spanning regions, and dilysine residues at 33 and 36,
relative to the C-terminus, probably locate it in the endoplas-
mic reticulum [20,21]. A further characteristic of all Elo-like
proteins described so far is the presence of the histidine box
motif HXXHH, which was also found in IgASE1, albeit with
glutamine (Q) substituted for the ¢rst histidine.
The amino acid sequence of IgASE1 exhibits only limited
similarity to the sequences of ELO-type genes (Fig. 2), with at
best only 27% identity with GLELO from M. alpina, which
elongates speci¢cally the two v6-desaturated C18 PUFAs,
GLA and STA [9]. The second highest identity of 26% was
found with Ssc1, which, together with Ssc2 (21% identity) and
Cig30 (20% identity), is a member of a mouse gene family
involved in the elongation of the very long chain fatty acids
that become esteri¢ed to sphingolipids [22,23]. Ssc1 could re-
place Elo3 to synthesise C26:0 for sphingolipid synthesis in a
yeast mutant, whilst Cig30 restored levels of C20^C24 fatty
acids in an Elo2-de¢cient mutant. IgASE1 shows 26% identity
Table 1
Composition of the major fatty acids of I. galbana











The microalgae were harvested after 1 month of growth in culture
as described in Section 2. Fatty acids were extracted and converted
to their methyl esters before analysis by GC. Each peak was identi-
¢ed by the retention time compared to known standards; values
represent the average of determinations made from three independ-
ent cultures.
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with human ELOVL4 and 24% identity with the mouse equiv-
alent Elovl4 [11], and 24%, 23% and 21% identity, respec-
tively, with the Elo3, Elo2 and Elo1 proteins from yeast [8].
The lowest identity value of 19% was found with F56H11.4
from C. elegans [10]. There is no obvious similarity between
IgASE1 and the plant condensing enzyme FAE1, which is
required for the synthesis of the mono-unsaturated fatty
acid, erucic acid (C22:1n-9, v13) in Arabidopsis [15].
3.2. Functional characterisation of IgASE1 in yeast
Further characterisation of IgASE1 was achieved by expres-
sion in yeast. The complete ORF was ampli¢ed from the
cDNA library and cloned in pCR2.1-TOPO. Recombinant
plasmids were screened for orientation of the insert to allow
subsequent excision with the 5P primer-encoded KpnI site and
the SacI site in the £anking vector sequence. The 5P KpnI site
also provided an A base at 33 with respect to the start codon
for e⁄cient translation initiation in yeast cells. The IgASE1
ORF was inserted into the yeast expression vector pYES2 to
create pY2ASE1, and this was transferred to the yeast strain,
W303-1A.
To determine the substrate speci¢city of the IgASE1 prod-
Fig. 2. Alignment of the predicted protein sequence of I. galbana IgASE1 with sequences predicted from other known elongating activity genes.
ELOVL4 [11] and HELO1 [5] are from human; Elovl4 [11], Cig30, Ssc1 and Ssc2 [22,23] are from mouse; GLELO1 [9] is from M. alpina ;
F56H11.4 [10] is from C. elegans ; Elo1, Elo2 and Elo3 [8,19] are from yeast.
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uct, the transformed yeast cells were grown in minimal me-
dium with ra⁄nose as the carbon source and supplemented
with a range of individual long chain PUFAs. The results
(Fig. 3 and Table 2) show that when LA (18:2n-6, v9;12)
and ALA (18:3n-3, v9;12;15) were present in the medium,
EDA (20:2n-6, v11;14) and ETrA (20:3n-3, v11;14;17) accumu-
lated to 9.1 and 8.4 mol% of total fatty acids, respectively.
This represented about 45% conversion [product/(product+
Fig. 3. Gas chromatograms of fatty acid methyl esters extracted from transformed yeast containing pY2ASE1. Yeast cultures were grown in
the absence (3SUB) or presence (+LA, +GLA, +ALA) of exogenous fatty acid substrates. Exogenous fatty acids (in the form of their sodium
salts) were linoleic acid (18:2n-6, v9;12, +LA), Q-linolenic acid (18:3n-6, v6;9;12, +GLA) and K-linolenic acid (18:3n-3, v9;12;15, +ALA); peaks
corresponding to added substrates are indicated by asterisks in the GC traces of uninduced cultures. Expression of IgASE1 was induced by the
addition of galactose to 2%. Yeast cells were harvested after 48 h and fatty acids extracted and assayed as their methyl esters using standard
methods. Peaks were identi¢ed by co-migration with known standards. Arrows in induced +LA and +ALA traces indicate novel peaks, which
were con¢rmed by GC-MS as EDA (20:2n-6, v11;14) and ETrA (20:3n-3, v11;14;17), respectively.
Table 2
Fatty acid elongation of di¡erent substrates supplied to yeast cells transformed with pY2ASE1
Fatty acid Mol% of fatty acid
3substrate +LA (18:2n-6) +ALA (18:3n-3) +GLA (18:3n-6)
+gal 3gal +gal 3gal +gal 3gal +gal 3gal
16:0 28.7 30.2 27.0 28.9 26.6 28.9 30.3 31.0
16:1n-9 41.6 42.4 30.7 25.4 30.1 26.4 24.3 24.6
18:0 6.8 6.1 5.7 5.8 6.3 6.3 6.8 6.2
18:1n-9 22.9 21.3 16.5 13.4 18.4 16.6 14.7 13.4
18:2n-6* ^ ^ 11.0 26.5 ^ ^ ^ ^
18:3n-6* ^ ^ ^ ^ ^ ^ 24.2 24.8
18:3n-3* ^ ^ ^ ^ 10.2 21.8 ^ ^
20:2n-6 ^ ^ 9.1 ^ ^ ^ ^ ^
20:3n-3 ^ ^ ^ ^ 8.4 ^ ^ ^
% elongation 0 0 45.3 ^ 45.2 ^ 0 ^
Exogenous fatty acids supplied as substrates for elongation are indicated by asterisks. The values given are expressed as mol% of total fatty
acid methyl esters identi¢ed by GC and £ame ionization detection. In the case of elongated substrates, this is also expressed as % elongation
(product/(product+substrate)U100). Expression of the IgASE1 transgene was induced by the addition of galactose. Only C18 substrates with a
double bond at the v9 position were elongated by the IgASE1. All values are the means of triplicates from three separate experiments.
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substrate)U100] of both C18 fatty acid substrates into C20
fatty acids after 48 h growth of the transformed yeast cells.
GLA (18:3n-6, v6;9;12) was not elongated in the transformed
yeast (Fig. 3). Other fatty acids, such as 16:1n-7, v9, 18:1n-9,
v9, 18:4n-3, v6;9;12;15, 20:5n-3, v5;8;11;14;17 and 22:5n-3,
v7;10;13;16;19, were also found to be inactive, however, the sub-
strates were always recovered in lipid extracts of the cells
(data not shown). Although in these experiments the incorpo-
ration of putative fatty acid substrates into membrane com-
ponents was not investigated, it is noteworthy in the func-
tional characterisation of other fatty acid genes using the
yeast system [5,18,25] that the predicted fatty acid conversions
have always been observed. These data clearly demonstrate
that IgASE1 encodes a C18-v9-speci¢c PUFA-elongating ac-
tivity.
4. Discussion
We have used PCR in combination with a cDNA library
construction to isolate a sequence encoding a C18-v9-speci¢c
PUFA-elongating activity from the DHA-producing microal-
ga, I. galbana. The predicted polypeptide sequence shares only
limited identity (up to 27%) with other proteins characterised
as having related activity, such as GLELO from M. alpina,
human HELO1 and the protein encoded by F56H11.4 from
C. elegans. Other pair-wise alignments of Elo-like proteins
(data not shown) produce higher percentage identities, but
these probably re£ect more the sources of the genes rather
than any higher degree of functional relatedness. Hence align-
ments of the yeast proteins Elo1, Elo2 and Elo3 produce
identities in the range 45^56%, while the mammalian proteins
HELO1, ELOVL4/Elovl4, Ssc1 and Ssc2 generate identity
values in the range 41^57%. The lower identity values arising
from comparisons across taxonomic groupings (such as
IgASE1 with all the others) result from averaging relatively
high degrees of conservation over a limited ‘core region’ of the
proteins, with very little conservation over the large stretches
comprising the rest of the sequences. An e¡ect of this is to
maintain various consensus motifs identi¢ed in known exam-
ples of this category of protein, such as KXXEXXDT,
HXXMYXYY and TXXQXXQ, while FHXXHH is modi¢ed
to FH/QXXHH. This last motif is interesting because
H/QXXHH also comprises one of the three histidine boxes
identi¢ed in almost all membrane desaturases and other dioxy
iron cluster proteins [7], and deviation from the consensus of
HXXHH for the third histidine box to QXXHH is also ap-
parent in various so-called front-end desaturases, including
v5 desaturases from M. alpina [18,24] and C. elegans [25],
v6 desaturases from Anabaena [26] Borago [27] and C. elegans
[28], and the v8 desaturase from Euglena gracilis [6]. Histidine
boxes in desaturases and other dioxy iron protein clusters
have been implicated in the binding of di-iron [7], but it re-
mains to be determined whether they also play this role in
IgASE1 and other proteins with elongating activity.
S. cerevisiae possesses multiple fatty acid elongation sys-
tems [8,19], and so by providing the ubiquitous elongase com-
ponents the yeast expression system has proved a valuable
testing ground for characterising the function of putative fatty
acid-elongating condensing components from various sources
[9,10]. IgASE1 was strictly selective and could only elongate
the v9-desaturated C18 (g3 or g6) PUFAs, LA (18:2n-6,
v9;12) and ALA (18:3n-3, v9;12;15) to yield EDA (20:2n-6,
v11;14) and ETrA (20:3n-3, v11;14;17), respectively. For both
fatty acid substrates some 45% was converted to products in
the transformed yeast cells.
Some PUFA-elongating activities are active on a range of
substrates; human HELO1, for example, can elongate both
C18 and C20 to C20 and C22 PUFAs along both the g3 and
g6 pathways [5]. In contrast, GLELO1 from M. alpina
showed substrate discrimination, acting speci¢cally on the
two products of v6 desaturation, 18:3n-6 (v6;9;12) and 18:4n-
3 (v6;9;12;15) [9].
It is noteworthy that the gene from Euglena encoding a
v8 desaturase activity [6] is speci¢c for the elongation prod-
ucts of IgASE1, ETrA and EDA. This implies that the g3
(v8) desaturase pathway for the synthesis of EPA and DHA is
present in I. galbana (Fig. 1). It is uncertain, however, whether
this coexists with the g3 (v6) desaturase pathway (Fig. 1).
Fatty acid analysis of I. galbana (Table 1) showed the pres-
ence of 18:4n-3, v6;9;12;15, a fatty acid known to be speci¢cally
synthesised from ALA through the activity of a v6 desaturase
[28^30]. Providing 18:4n-3, v6;9;12;15 can be elongated to ETA
then this suggests that both g3 pathways may operate in
I. galbana for the production of long chain PUFAs.
The fact that the product of IgASE1 elongates 18:2 to EDA
(Table 2 and Fig. 3) and that the Euglena v8 desaturase can
act upon this product to produce 20:3n-6, v8;11;14 [6] is inter-
esting and implies that the g6 (v8) pathway (Fig. 1) should
also operate in I. galbana. Although no EDA, GLA or AA
could be detected in I. galbana it is possible that the enzymes
catalysing the synthesis of these intermediates and products
are relatively highly active and that there is a rapid £ux
through these parts of the pathway. Such a £ux is also evident
in the g3 pathways in that the intermediates ETrA and ETA
were also not detected in fatty acid analyses.
If an g6 (v8) pathway can operate in I. galbana then what
happens to the products 20:3n-6 and 20:4n-6? Work with M.
alpina [31] suggested the existence of a desaturase introducing
a double bond at the v17 position of AA to produce EPA, and
Spychalla et al. [32] have isolated a C. elegans glycerolipid
desaturase with g3 activity on a range of g6 fatty acid sub-
strates, including DGLA and AA. It is possible that a similar
desaturase activity is present in I. galbana, rapidly channelling
g6 (v8) desaturase pathway products into the g3 (v6) and g3
(v8) pathways for EPA and DHA production (Fig. 1). The
presence of 18:4n-3, v6;9;12;15 in I. galbana implies v6 desatur-
ase activity (see above). v6 desaturases are generally non-spe-
ci¢c for g3 and g6 C18 fatty acids, and can utilise both LA
and ALA [29,30]. If this were the case in I. galbana, one might
anticipate that the g6 (v6) pathway is also active, again with
the products rapidly transferred to g3 fatty acid synthesis via
v17 desaturation (Fig. 1). It is of course possible that the v6
desaturase is speci¢c for ALA and hence dedicated to g3 fatty
acid production. I. galbana, therefore, provides an excellent
experimental system for investigating g3 fatty acid biosynthe-
sis, the interactions between the v6 and v8 desaturase path-
ways and the possible involvement of g6 metabolism in the
production of EPA.
The isolation and characterisation of a novel PUFA elon-
gating activity from I. galbana, described in this paper, should
make a signi¢cant contribution to the determination of struc-
ture^function relationships in this class of protein. IgASE1
appears to be less closely related to the Elo-like proteins de-
scribed hitherto than they are to each other. It is distinct in
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having clear speci¢city for v9-desaturated C18 PUFAs, and
this may prove to be of biotechnological as well as biochem-
ical signi¢cance.
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